CD152 Rabbit Polyclonal Antibody
To Order: garrett@bioworldantibodies.com
CD152 Polyclonal Antibody |
ES8684-50ul |
ELK Biotech |
50ul |
EUR 207 |
Description: A Rabbit Polyclonal antibody against CD152 from Human. This antibody is tested and validated for IHC, WB, ELISA |
CD152 Polyclonal Antibody |
ABP58036-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
Description: A polyclonal antibody for detection of CD152 from Human. This CD152 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD152 protein at amino acid sequence of 41-90 |
CD152 Polyclonal Antibody |
ABP58036-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
Description: A polyclonal antibody for detection of CD152 from Human. This CD152 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD152 protein at amino acid sequence of 41-90 |
CD152 Polyclonal Antibody |
ABP58036-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
Description: A polyclonal antibody for detection of CD152 from Human. This CD152 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD152 protein at amino acid sequence of 41-90 |
CD152 Polyclonal Antibody |
46815-100ul |
SAB |
100ul |
EUR 252 |
CD152 Polyclonal Antibody |
46815-50ul |
SAB |
50ul |
EUR 187 |
CD152 antibody |
10R-CD152aMS |
Fitzgerald |
500 ug |
EUR 370 |
Description: Hamster monoclonal CD152 antibody |
CD152 antibody |
10R-CD152bMS |
Fitzgerald |
500 ug |
EUR 370 |
Description: Hamster monoclonal CD152 antibody |
CD152 Antibody (FITC) |
abx133968-100Assays |
Abbexa |
100 Assays |
EUR 439 |
|
CD152 Antibody (FITC) |
abx133968-50Assays |
Abbexa |
50 Assays |
EUR 342 |
|
Anti-CD152 Antibody |
A00020 |
BosterBio |
100ul |
EUR 397 |
Description: Rabbit Polyclonal Antibody for CD152 Antibody (CTLA4) detection.tested for IHC in Human. |
CD152 Antibody (Biotin) |
20-abx200697 |
Abbexa |
|
|
|
CD152 Antibody (FITC) |
20-abx200699 |
Abbexa |
|
|
|
Anti-CD152 antibody |
STJ98747 |
St John's Laboratory |
200 µl |
EUR 197 |
Description: Rabbit polyclonal to CD152. |
Anti-CD152 Antibody |
A1388-100 |
Biovision |
|
EUR 370 |
CD152 antibody (PE) |
61R-1314 |
Fitzgerald |
100 ug |
EUR 354 |
Description: Mouse monoclonal CD152 antibody (PE) |
CD152 antibody (biotin) |
61R-CD152aMSBT |
Fitzgerald |
500 ug |
EUR 446 |
Description: Hamster monoclonal CD152 antibody (biotin) |
CD152 antibody (FITC) |
61R-CD152aMSFT |
Fitzgerald |
500 ug |
EUR 457 |
Description: Hamster monoclonal CD152 antibody (FITC) |
CD152 antibody (PE) |
61R-CD152aMSPE |
Fitzgerald |
100 ug |
EUR 300 |
Description: Hamster monoclonal CD152 antibody (PE) |
CD152 (CTLA-4) Antibody |
abx021366-02mg |
Abbexa |
0.2 mg |
EUR 1017 |
|
CD152 antibody (Azide Free) |
10R-CD152aMSP |
Fitzgerald |
500 ug |
EUR 457 |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
CD152 antibody (Azide Free) |
10R-CD152bMSP |
Fitzgerald |
500 ug |
EUR 457 |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
Anti-CTLA4 (CD152) Monoclonal Antibody |
M00020 |
BosterBio |
100ug |
EUR 397 |
Description: Rabbit Monoclonal CTLA4 (CD152) Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat. |
Hamster Anti CTLA-4 (CD152) Antibody |
20-abx137133 |
Abbexa |
|
|
|
Anti-Hu CD152 APC |
1A-785-T100 |
ExBio |
100 tests |
EUR 240 |
Anti-Hu CD152 PE |
1P-785-T025 |
ExBio |
25 tests |
EUR 140 |
Anti-Hu CD152 PE |
1P-785-T100 |
ExBio |
100 tests |
EUR 240 |
Anti-Hu CD152 Purified |
11-785-C025 |
ExBio |
0.025 mg |
EUR 99 |
Anti-Hu CD152 Purified |
11-785-C100 |
ExBio |
0.1 mg |
EUR 158 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
20-abx133970 |
Abbexa |
-
EUR 356.00
-
EUR 565.00
-
EUR 300.00
|
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx413284-02mg |
Abbexa |
0.2 mg |
EUR 676 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx413702-025mg |
Abbexa |
0.25 mg |
EUR 565 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx414772-025mg |
Abbexa |
0.25 mg |
EUR 565 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx414773-05mg |
Abbexa |
0.5 mg |
EUR 829 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx414774-01mg |
Abbexa |
0.1 mg |
EUR 439 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
20-abx225129 |
Abbexa |
-
EUR 370.00
-
EUR 606.00
-
EUR 314.00
|
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
20-abx200703 |
Abbexa |
|
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx139385-01mg |
Abbexa |
0.1 mg |
EUR 356 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
abx139386-01mg |
Abbexa |
0.1 mg |
EUR 356 |
|
Anti-Hu CD152 Alexa Fluor647 |
A6-785-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD152 PE-Cy7 |
T7-785-T100 |
ExBio |
100 tests |
EUR 268 |
Anti-Hu CD152 PE-Cy5 |
T8-785-T100 |
ExBio |
100 tests |
EUR 240 |
CTLA4 /CD152 (Human) ELISA Kit |
K4157-100 |
Biovision |
|
EUR 827 |
CD152 [CTLA-4] Recombinant Protein |
90-411 |
ProSci |
100 ug |
EUR 285.5 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
90-412 |
ProSci |
500 ug |
EUR 464 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
90-415 |
ProSci |
100 ug |
EUR 364.25 |
Description: CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4 + and CD8 + T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4 + T cells and 50% of CD8 + T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
90-416 |
ProSci |
100 ug |
EUR 311.75 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
90-417 |
ProSci |
500 ug |
EUR 490.25 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
abx133969-100Assays |
Abbexa |
100 Assays |
EUR 495 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
abx133969-50Assays |
Abbexa |
50 Assays |
EUR 398 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
abx413285-100tests2ml |
Abbexa |
100 tests (2 ml) |
EUR 592 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
abx413286-25tests |
Abbexa |
25 tests |
EUR 314 |
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (APC) |
20-abx200696 |
Abbexa |
|
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PerCP) |
20-abx200701 |
Abbexa |
|
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
abx139387-100tests |
Abbexa |
100 tests |
EUR 481 |
|
Anti-CD152/ CTLA-4 Antibody [BNI3], Unconjugated-100ug |
QAB59-100ug |
EnQuireBio |
100ug |
EUR 200 |
Anti-CD152/ CTLA-4 Antibody [BNI3], APC-100Tests |
QAB59-APC-100Tests |
EnQuireBio |
100Tests |
EUR 352 |
Anti-CD152/ CTLA-4 Antibody [BNI3], APC-25Tests |
QAB59-APC-25Tests |
EnQuireBio |
25Tests |
EUR 157 |
Anti-CD152/ CTLA-4 Antibody [BNI3], PE-100Tests |
QAB59-PE-100Tests |
EnQuireBio |
100Tests |
EUR 259 |
Anti-CD152/ CTLA-4 Antibody [BNI3], PE-25Tests |
QAB59-PE-25Tests |
EnQuireBio |
25Tests |
EUR 149 |
Anti-Hu CD152 Purified Low Endotoxin |
12-785-C100 |
ExBio |
0.1 mg |
EUR 158 |
Recombinant Human CTLA-4/CD152 Protein |
RP00343 |
Abclonal |
10 μg |
EUR 145 |
Recombinant Mouse CTLA-4/CD152 Protein |
RP00755 |
Abclonal |
10 μg |
EUR 145 |
Human CellExp? CTLA4/CD152, human recombinant |
7476-100 |
Biovision |
|
EUR 626 |
Human CellExp? CTLA4/CD152, human recombinant |
7476-20 |
Biovision |
|
EUR 224 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (CF-Blue) |
20-abx200698 |
Abbexa |
|
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PerCP-Cy5.5) |
20-abx200702 |
Abbexa |
|
|
|
Anti-CD152/ CTLA-4 Antibody [BNI3], Qfluor 630-100ug |
QAB59-QF630-100ug |
EnQuireBio |
100ug |
EUR 276 |
Recombinant Cynomolgus CD152/CTLA-4 (C-6His) |
C957-10ug |
Novoprotein |
10ug |
EUR 100 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Cynomolgus CD152/CTLA-4 (C-6His) |
C957-1mg |
Novoprotein |
1mg |
EUR 1115 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Cynomolgus CD152/CTLA-4 (C-6His) |
C957-500ug |
Novoprotein |
500ug |
EUR 796 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Cynomolgus CD152/CTLA-4 (C-6His) |
C957-50ug |
Novoprotein |
50ug |
EUR 171 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Human CellExp? CTLA-4/CD152, mouse recombinant |
P1081-10 |
Biovision |
|
EUR 142 |
Human CellExp? CTLA-4/CD152, mouse recombinant |
P1081-50 |
Biovision |
|
EUR 457 |
CD152 [CTLA-4] non-lytic Recombinant Protein |
90-413 |
ProSci |
100 ug |
EUR 311.75 |
Description: CD152 (CTLA-4) and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally_x000D_ homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an_x000D_ intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by_x000D_ cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+_x000D_ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation._x000D_ Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] non-lytic Recombinant Protein |
90-414 |
ProSci |
500 ug |
EUR 490.25 |
Description: CD152 (CTLA-4) and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally_x000D_ homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an_x000D_ intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by_x000D_ cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+_x000D_ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation._x000D_ Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] non-lytic Recombinant Protein |
90-418 |
ProSci |
100 ug |
EUR 311.75 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] non-lytic Recombinant Protein |
90-419 |
ProSci |
500 ug |
EUR 490.25 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 Rabbit Polyclonal Antibody